Skip to main content

From the 2023 4th Quarter Pressure

Elaine M. Silverman, MD, MPH
Linda Zhang, MS
Jay C. Buckey, MD

Multicenter Hyperbaric Outcomes Registry: 2023 Q4 Update

The Multicenter Registry for Hyperbaric Oxygen Treatment includes 26 centers that agree to enter standard outcome measures on all the patients they see. These data are being published to inform the medical community about the uses of hyperbaric oxygen treatment and the outcomes. 

Recent Manuscripts from The Multicenter HBOT Registry 

Two manuscripts based on registry data have been submitted recently and are under review: 

Manuscript #1, Submitted to the Journal of Medical Internet Research: 
“Emerging Indications for Hyperbaric Oxygen Treatment: A Registry Cohort Study” 
Hideaki L. Tanaka, MD et al. for The Multicenter Registry for Hyperbaric Oxygen Treatment Consortium 

This retrospective study describes the outcomes from cases within the registry that were outside of the 14 established diagnoses approved for HBO2 by UHMS. It highlights how that information can potentially promote further study of and use of HBO2

Summary of other indications. Some of the indications were case series with several cases.  Others were case reports of individual cases. 

Indication  Total  Indication  Total 
Post COVID syndrome  148  Vasculitic ulcer 
Ulcerative colitis  45  BK virus cystitis 
Crohn's disease  34  Levamisole vasculitis 
Calciphylaxis  18  Graft vs host disease 
Peripheral vascular disease ulcer  11  Decubitus ulcer 
Acute COVID-19  Greater trochanteric pain syndrome 
Frostbite  Rectovaginal fistula 
Pterygium  Argon poisoning 
Osteonecrosis/Avascular necrosis  Pouchitis 
Pyoderma gangrenosum  Chemotherapy-related bladder ulcer 
Head trauma  Post-surgery in irradiated tissue 
Infected implanted hardware  Recurrent perianal abscess 
Pneumatosis intestinalis  Tinnitus 
Facial filler  Clostridium enterocolitis 
Ischemic bowel  Ligament/Cartilage injury 
Raynaud's syndrome  Branch retinal artery occlusion 
Malignant otitis externa  Axonotmesis 
Non arteritic anterior ischemic optic neuropathy  Non healing bowel anastomosis 
Central retinal vein occlusion  Multiple sclerosis 
Cyclophosphamide cystitis  Inclusion body myositis 
Femoral head necrosis  Epidermolysis bullosa 
Invasive fungal infection     
Chronic anal fissure     

 

Fistula Discharge Crohn’s Violin Chart 
Reported fistula discharge pre and post HBO2 in patients with Crohn’s disease who had complete pre and post HBO2 data

fistula


Manuscript #2, Submitted to the Journal of Urology : 
“Patient Reported Outcome Measures following Hyperbaric Oxygen Therapy for Radiation Cystitis: Results from the Multicenter Registry for Hyperbaric Oxygen Therapy” 
Rachel Moses MD, MH, et al., for The  Multicenter Registry for Hyperbaric Oxygen Treatment Consortium 

This was a prospective cohort study looking at registry patients treated for radiation cystitis.  The results show a significant association between HBOT and improved patient-reported urinary symptoms. 

Urogenital distress inventory scores
Urogenital Distress Inventory scores pre/post HBO2
UDI

Hematuria Scores pre and post HBO2
Mean and median Radiation Therapy Oncology Group (RTOG) hematuria scores pre and post HBO2 therapy

Hematuria

The multicenter registry is a valuable tool for evaluating standardized treatment outcomes, both in established and emerging indications for HBO2.

If your center is not already contributing to the registry, please consider joining the consortium! More information may be obtained through this link:

Multicenter Registry for Hyperbaric Oxygen Therapy - Undersea & Hyperbaric Medical Society (uhms.org)